BridgeMD

Sign in

Dry eye disease clinical trials

Explore recruiting dry eye disease clinical trials.

Recruiting dry eye disease studies right now

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Dry eye disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Randomized, double-blind, parallel group clinical trial to evaluate the efficacy and safety of PRGF eye drops as a treatment for dry eye disease in patients with glaucoma

Spain

Phase III and phase IV (Integrated) EU CTIS Study details

Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Randomized, parallel-group, double-blind clinical trial to evaluate the efficacy and safety of PRGF eye drops in patients with dry eye disease

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Randomized, parallel-group, double-blind clinical trial to evaluate the efficacy and safety of PRGF eye drops in patients with dry eye disease

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Clinical Trial To Determine The Efficacy And Safety Of Insulin Eye Drops In Dry Eye In Patients With Topical Hypotensors

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Phase IIB Clinical Trial to evaluate the efficacy and safety of Allogeneic Mesenchymal Stem Cell (MSC) eye injection treatment as therapy for Graft-versus-Host Disease (GvHD) refractory to conventional treatments

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Dry eye disease trials by city

Dry eye disease in Toronto Dry eye disease in Vancouver Dry eye disease in Montreal Dry eye disease in Calgary Dry eye disease in Edmonton Dry eye disease in Ottawa Dry eye disease in Winnipeg Dry eye disease in Quebec City Dry eye disease in Hamilton Dry eye disease in Kitchener Dry eye disease in London Dry eye disease in Halifax Dry eye disease in New York Dry eye disease in Los Angeles Dry eye disease in Chicago Dry eye disease in Houston